Clinical Trial Update: Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2 [Phase 2, Phase 3]

View source ↗

Summary

Pivotal study update for fexinidazole in stage 2 human African trypanosomiasis (sleeping sickness) with completed status across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human African Trypanosomiasis
• Sleeping Sickness

Drugs mentioned

• Fexinidazole (fexinidazole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Human African Trypanosomiasis (HAT), Sleeping Sickness | Phase 2, Phase 3 | Status: COMPLETED